From Reuters Health:http://www.reuters.com/article/2015/02/16/us-endocrinology-diabetes-race-pediatric-idUSKBN0LK1TR20150216 Reuters Health Social and economic status does not explain the racial gaps in the care and outcomes of kids with type 1 diabetes, according to a new study. The finding suggests researchers look to other factors that may explain the racial gap in type 1 diabetes care, such as the perceptions of […]
Category: The issues (Page 5)
From:http://www.nih.gov/news/health/feb2015/niams-17.htm nvestigators with the National Institutes of Health have discovered the genomic switches of a blood cell key to regulating the human immune system. The findings, published in Nature today, open the door to new research and development in drugs and personalized medicine to help those with autoimmune disorders such as inflammatory bowel disease or […]
Advocates can join the American Diabetes Association in askingCongress to stand up against diabetes bysigning theirpetition asking Congress to act by: Allocating $2.066 billion for the National Institutes of Healths (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the primary federal agency that conducts research to find a cure and advance treatments […]
Fromhttp://www.healio.com* Researchers suggest thatobesityis a chronic disease with a number of biological causes that make it impossible to be cured withdiet and exercisealone in a recently published comment inThe Lancet Diabetes & Endocrinology. Eighty percent to 95% of people with obesity who lose weight eventually regain it. Several biological systems are triggered when caloric intake […]
From:http://www.endocrinologyadvisor.com/diabetes-patients-skipping-doctors-visits/article/396176/ (HealthDay News) One in every five young American adults with diabetes has not seen a doctor in the past 6 months, according to a data brief published by the U.S. Centers for Disease Control and Preventions National Center for Health Statistics. Ongoing medical care is recommended for persons of any age who havediabetesin order […]
From:http://www.diabeteseducator.org/About/Media/02.03.15_Release For Release: February 3, 2015 A survey conducted by the American Association of Diabetes Educators (AADE) has found that suppliers selected to participate in Medicares competitive bidding program are failing to provide access to insulin pumps and related supplies. This failure to comply with the program results in limited access to necessary equipment for […]
From:http://www.medpagetoday.com/Endocrinology/Diabetes/49849 The FDA has approved the first combination pill of an SGLT2 inhibitor and a DPP-4 inhibitor, to be marketed as Glyxambi, drugmakers Eli Lilly and Boehringer Ingelheim announced. The combination of 10 or 25 mg of empagliflozin and 5 mg of linagliptin is approved as an adjunct to diet and exercise to improve glycemic […]
ARIS (Reuters) Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life. Developed by Mannkind Corp, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Lilly and Novo Nordisk for sales […]
THE WHITE HOUSE Office of the Press Secretary FOR IMMEDIATE RELEASE January 30, 2015 FACT SHEET:President Obamas Precision Medicine Initiative Building on President Obamas announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and […]
Dapagliflozin combination improved glycemic control, reduced body weight in type 2 diabetes Matthaei S.Diabetes Care.2015;doi:10.2337/dc14-0666. Stephan Matthaei, MD,of the Diabetes-Zentrum Quakenbrck in Germany, and colleagues evaluated participants (mean age, 61 years) with an HbA1c of 7% to 10.5% receiving sulfonylurea andmetforminwho were assigned to receivedapagliflozin(Farxiga, Bristol-Myers Squibb and AstraZeneca) 10 mg/day (n=109) or placebo (n=109) […]